Subscriber access provided by Gothenburg University Library
Communication
Enzymatic Cleavage of Branched Peptides for Targeting Mitochondria Hongjian He, Jiaqing Wang, Huaimin Wang, Ning Zhou, Dongsik Yang, Douglas R Green, and Bing Xu J. Am. Chem. Soc., Just Accepted Manuscript • DOI: 10.1021/jacs.7b11582 • Publication Date (Web): 12 Jan 2018 Downloaded from http://pubs.acs.org on January 12, 2018
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Journal of the American Chemical Society is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of the American Chemical Society
Enzymatic Cleavage of Branched Peptides for Targeting Mitochondria Hongjian He†, Jiaqing Wang†, Huaimin Wang†, Ning Zhou†, Dongsik Yang†, Douglas R. Green§ and Bing Xu*, † † §
Department of Chemistry, Brandeis University, 415 South St., Waltham, MA 02454, USA. Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
Supporting Information Placeholder ABSTRACT: Most of the reported mitochondria targeting molecules are lipophilic and cationic, which may become cytotoxic with accumulation. Here we show enzymatic cleavage of branched peptides that carry negative charges for targeting mitochondria. Conjugating a well-established protein tag (i.e., FLAG-tag) to self-assembling motifs affords the precursors that form micelles. Enzymatic cleavage of the hydrophilic FLAG motif (DDDDK) by enterokinase (ENTK) turns the micelles to nanofibers. After being taken up by cells, the micelles, upon the action of intracellular ENTK, turns into nanofibers to locate mainly at mitochondria. The micelles of the precursors are able to deliver cargos (either small molecules or proteins) into cells, largely to mitochondria and within two hours. Preventing ENTK proteolysis diminishes mitochondria targeting. As the first report of using enzymatic self-assembly for targeting mitochondria and delivery cargos to mitochondria, this work illustrates a fundamentally new way to target subcellular organelles for biomedicine.
As a subcellular organelle, mitochondria plays essential roles in many cellular processes, such as apoptosis and metabolism.1 Intensive research efforts have focused on developing therapeutics that target mitochondria.2 In fact, some of the therapeutics have already entered clinical trials.3 Except gramicidin S derivatives developed by Wipf et. al.,2a most of the molecules reported for targeting mitochondria are lipophilic and cationic.4 Although those lipophilic cations are able to prevent mitochondrial damage in vitro, they have a major drawback due the toxicity resulted from the accumulation in the mitochondrial matrix.5 Thus, it is necessary to develop new molecules or processes for targeting mitochondria. We have been exploring enzyme-instructed self-assembly (EISA),5 a multistep molecular process that is finding increasing number of applications,6 including selective inhibiting cancer cells.7 During our study on enzymatic supramolecular hydrogelation of branched peptides6, we serendipitously found that EISA of branched peptides is able to target mitochondria. Here we show enzymatic cleavage of branched peptides that carry negative charges for targeting mitochondria. Conjugating a well-established protein tag (i.e., FLAG-tag)7 to selfassembling motifs8 affords the precursors that are the substrates of enterokinase (ENTK).9 The precursors form micelles,
which turn into nanofibers upon enzymatic cleavage of the hydrophilic branch that contains FLAG motif (DDDDK).7 Fluorescent microscopy of live cells reveals that, after being taken up by cells, the branched peptides and their enzyme cleaved products, mainly localize at mitochondria. Moreover, the micelles of the precursors are able to deliver cargos (either small molecules (e.g., doxorubicin (Dox)) or proteins (e.g., red phycoerythrin (RPE)10)) into cells, largely to mitochondria and within two hours. Western blot indicates ENTK on the isolated mitochondria of cancer cells. Transmission electron microscopy (TEM) of the isolated mitochondria confirms the conversion of the micelles to nanofibers at the mitochondria. Preventing ENTK proteolysis diminishes the mitochondria targeting. These results confirm EISA as the process for targeting mitochondria. As the first report of using EISA for targeting mitochondria and delivery molecular cargos to mitochondria (Scheme 1), this work illustrates a fundamentally new molecular motif and process for targeting mitochondria and exploring the applications of protease-instructed assembly for biomedicine. Scheme 1. Structure of a representative branched peptide and ENTK cleaving the branch to convert micelles to nanofibers on mitochondria.
ACS Paragon Plus Environment
Journal of the American Chemical Society 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Scheme 1 shows the structure of the designed substrate of ENTK. We use the symbol “₸” to represent the branching so that the substrate is denoted as D-1₸FLAG. The branched peptides consist of (i) the FLAG-tag (DYKDDDDK)7 as the substrate of ENTK for enzymatic recognition and cleavage, (ii) a self-assembling peptide sequence D-1 composed of a 2acetylnaphthyl group (Nap), a D-tripeptide (D-Phe-D-Phe-DLys (ffk)), and a nitrobenzoxadiazoly-ethylenediamino moiety (NBD-EA, for enhanced fluorescence upon self-assembly11) at the C-terminal of the D-peptide, and (iii) a glycine as the spacer for (i) and (ii). Using Fmoc-based solid-phase peptide synthesis,12 we first produce the peptide segments (i.e., FLAGGly and the Nap-ffk, Scheme S1). After the synthesis, we generate D-1 by conjugating NBD-EA the Nap-ffk via C-terminal activation. Subsequently, we connect the C-terminal of FLAGGly to the side chain of lysine in D-1 using the same activation method. Finally, the removal of all protecting groups and the purification by high pressure liquid chromatography (HPLC) produce the designed branch peptide (i.e., D-1₸FLAG).
The pattern of the distribution of D-1₸FLAG in cytosol resembles to that of mitochondria (Figures 1B and S7). Costaining D-1₸FLAG with MitoTracker or Lyso-tracker in HeLa cells shows that the yellow fluorescence from D1₸FLAG mostly overlaps with the red fluorescence of MitoTracker (Figure 1C), but co-localizes poorly with the fluorescence from Lyso-tracker (Fig. S8). These results suggest that D-1₸FLAG, escaping lysosomes after endocytosis, specifically localizes in mitochondria. However, HeLa cells treated by D-1 exhibit fluorescence both outside the cells (including membrane) and in cytosol nonspecifically (Fig. S9). Thus, we infer that the mitochondria-targeting ability of D-1₸FLAG likely depends on its unique branching architecture, as well as the electrostatic interaction between the FLAG-tag moiety (negative potential, due to carboxylic groups) and the intermembrane space of mitochondria (positive potential, resulted from abundant H+),14 as illustrated in Scheme 1. Notably, D1₸FLAG appears to accumulate in the lysosomes of a normal cell line (HS-5) (Fig. S10). Such cell selectivity worth further investigation. Moreover, after mixing R-phycoerythrin (RPE), a protein, with D-1₸FLAG, we incubate them with HeLa cells for two hours. While the control cells (without micelles) show little fluorescence (Fig. S11), RPE and D-1₸FLAG localize in the mitochondria (Figure 1D). TEM of the mixture of RPE and D-1₸FLAG support the encapsulation of RPE by the micelles (Fig. S12). These results indicate that the micelles formed by D-1₸FLAG are able to deliver cargo molecules to mitochondria.
Figure 1. (A) TEM images of D-1₸FLAG before (left) and after (right) adding ENTK (24 h), scale bar = 100 nm. (B) Fluorescent images of HeLa and U87MG cells incubated with D-1₸FLAG for 2 h. (C) The fluorescence images of D-1₸FLAG and MitoTracker in HeLa cells. (D) HeLa cells treated by the mixture of RPE (1 µg/mL) and D-1₸FLAG for 2 h. Scale bar = 30 µm in (B, C). The concentrations of D-1₸FLAG are 200 µM for A-D.
D-1₸FLAG forms nanoparticles (46±11 nm in diameter) at 200 µM (critical micelle concentration (CMC), Fig. S1), which become nanofibers (18±3 nm in diameter) upon the addition of ENTK (Figure 1A, S2 and S3). Circular dichroism (CD) measurement indicates the cleavage of the branch results in largely β-sheet (D-1) and random-coil (FLAG-tag) like secondary structures for the case of D-1₸FLAG (Fig. S4), as well as for those of D- and L-2₸FLAGs.6 After the incubation of HeLa or U87MG cells with D-1₸FLAG for two hours, fluorescent imaging (Figure 1B) of these the cells exhibits strong fluorescence, indicating a rapid cellular uptake of D-1₸FLAG. Our prelimilary endocytosis study suggests that the uptake of the precursors by HeLa cells likely involves macropinocytosis and clathrin-dependent pathway (Fig. S5). Cell viability assay reveals that D-1₸FLAG exhibits little cytotoxicity to HeLa and U87MG cells (Fig. S6), excluding the possibility that the rapid internalization of D-1₸FLAG originates from the increased membrane permeability caused by cell death.13
Figure 2. (A, B) HeLa cells incubated with (A) RPE (1 µg/mL) and (B) Dox (2 µM) mixing with D-2₸FLAG and L-2₸FLAG (200 µM) for 2 h. (C) GFP-cyt c HeLa cells treated by the mixture of RPE (1 µg/ml) and D-2₸FLAG (200 µM) for 2 h. Scale bar = 30 µm. (D) Co-localization analysis of GFP-cyt c and Omimcherry expressing HeLa cells treated by RPE or Dox in the presence of D-2₸FLAG. R=1 indicates perfect co-localization.
Mitochondria targeting of D-1₸FLAG implies that the micelles formed by other FLAG-tagged precursors made of branched peptides would localize and deliver cargo molecules to mitochondria. Thus, we examine whether precursors D2₸FLAG (an analog of D-1₸FLAG without NBD, Scheme
ACS Paragon Plus Environment
Page 2 of 5
Page 3 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of the American Chemical Society S2) and L-2₸FLAG (a diastereomer of D-2₸FLAG) are able to deliver cargo molecules to mitochondria. The similar CMC values of D-1₸FLAG and D-2₸FLAG (Fig. S1) support the interchangeability between them. After mixing RPE, a protein, or doxorubicin (Dox), a drug molecule, with L-2₸FLAG or D-2₸FLAG, we incubate them with HeLa or U87MG cells for two hours. While the control cells (without the micelles formed by the precursors) show little fluorescence (Fig. S11), the cells incubated with the micelles and the cargo molecules exhibit strong fluorescence (Figure 2A and B), indicating that the intracellular delivery of RPE and Dox by L-2₸FLAG or D-2₸FLAG. Similar to D-1₸FLAG, the patterns of the distribution of RPE (or Dox) inside the cells are akin to that of mitochondria. To further verify whether the FLAG-tagged precursors deliver cargo molecules to mitochondria specifically, we incubate the HeLa cells expressing GFP-Cyt c15 or Omi-mcherry16 (in mitochondria) with RPE or Dox in the presence of D2₸FLAG. Fluorescent images confirm that the fluorescence of RPE or Dox extensively overlaps with that from GFP-cyt c and Omi-mcherry (Figures 2C and S13). Quantification of the overlap of the fluorescence17 confirm that RPE or Dox alone hardly co-localize with mitochondria, but D-2₸FLAG significantly boost the localization of RPE or Dox in mitochondria (Figure 2D). Moreover, Dox, after mixing with D-2₸FLAG or L-2₸FLAG, exhibits significantly increased cytotoxicity against HeLa cells compared to Dox only. That is, the branched peptide precursors decrease the IC50 of Dox from 3.0 µM to 400 nM (Fig. S14D). In addition, D-2₸FLAG significantly boosts the activity of Dox against Dox-resistant cancer cell line (MESA/Dx5,18 Fig. S14D). The synergistic effect (Fig. S14E) of Dox and the FLAG-tagged precursors against cancer cells likely originates from that the micelles enhance the uptake of Dox and Dox interfering with mitochondrial DNA. These results confirm that the generality of the FLAG-tagged branch peptide precursors serve as carriers for delivering cargo molecules to mitochondria.
light chain19), suggesting the presence of ENTK on mitochondria. Moreover, LC/MS analysis of the isolated mitochondria confirmed that D-2 is the main component of the nanofibers (Fig. S17), indicating that D-2₸FLAG, after reaching mitochondria, is cleaved by ENTK. The in-situ formation of nanofibers results in the localization of the nanofibers at mitochondria. To verify whether the proteolysis is necessary for mitochondria targeting, we made the D-peptide control (D-1₸flag) by connecting D-1 to the D-enantiomer of FLAG tag (flag), which is resistant to ENTK. The fluorescent images of HeLa cells incubated with D-1₸flag (200 µM, 2h) failed to exhibit a mitochondria-specific distribution (Fig. S18), suggesting that the prevention of proteolysis (the conversion to nanofibers) catalyzed by ENTK abolishes the mitochondria targeting. In conclusion, we demonstrate the branched peptides as a novel type of substrates for enzymatic self-assembly to target mitochondria. Although carrying multiple negative charges, the FLAG-tagged precursors undergo rapid endocytosis and specifically accumulate in mitochondria. The deposition of the nanofibers affect little on the cellular activity, likely due to that the nanofibers impact less than cationic molecules on the membrane potential of mitochondria. The branch architecture is uniquely important for targeting mitochondria since the linear peptide, L-2-FLAG, is unable to deliver cargo molecule to mitochondria (Fig. S19). This work highlights the importance of reactions, in addition to nanoarchitectonics,20 for controlling biological systems. Contrasting to most of the reported mitochondria targeting molecules that usually are lipophilic and cationic,7 this observation illustrates a new mechanism, the integration of enzymatic reaction and self-assembly (i.e., EISA), for targeting mitochondria, which would complement other approaches (e.g., triphenyl phosphonium (TPP)21). Although the targeting of mitochondria relies on ENTK in this work, the strategy demonstrated here should allow the development of the substrate of other enzymes on mitochondria for mitochondria targeting. Among numerous approaches for mitochondria-specific drug delivery,22 the delivery of cargo molecules to target mitochondria by the FLAG-tagged precursors is particularly promising and worth further exploration for potential applications in biomedicine because of the cell compatibility of the FLAG-tagged precursors (Fig. S9A) and the biological importance of mitochondria.23
ASSOCIATED CONTENT Supporting Information Figure 3. TEM images of mitochondria isolated from HeLa cells being incubated with D-2₸FLAG (200 µM) for (A) 2h and (B) 24 h. Scale bar equals 100 nm.
To confirm that the nanofibers form at mitochondria after ENTK cleaves the branch of the branched peptides, we isolated mitochondria from HeLa cells incubated with D-2₸FLAG (200 µM) for different time (Figure 3 and S15). The cells treated by D-2₸FLAG for 2 h and 24 h produce mitochondria surrounded by nanoparticles and nanofibers, respectively (Figure 3), while the mitochondria from the HeLa cells incubated with only culture medium exhibit a surface without either nanoparticles or nanofibers (Fig. S15). Western blot analysis of the mitochondria isolated from HeLa and U87MG cells showed two ENTK bands (Fig. S16, the major band is the
This material is available free of charge via the Internet at http://pubs.acs.org.
AUTHOR INFORMATION Corresponding Author
[email protected] Notes The authors declare no competing financial interests.
ACKNOWLEDGMENT This work was partially supported by NIH (R01CA142746) and NSF (MRSEC-1420382).
REFERENCES
ACS Paragon Plus Environment
Journal of the American Chemical Society 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
(1) (a) Green, D. R.; Kroemer, G., Science 2004, 305 (5684), 626; (b) McBride, H. M.; Neuspiel, M.; Wasiak, S., Curr. Biol. 2006, 16 (14), R551; (c) Kujoth, G. C.; Hiona, A.; Pugh, T. D.; Someya, S.; Panzer, K.; Wohlgemuth, S. E.; Hofer, T.; Seo, A. Y.; Sullivan, R.; Jobling, W. A.; Morrow, J. D.; Van Remmen, H.; Sedivy, J. M.; Yamasoba, T.; Tanokura, M.; Weindruch, R.; Leeuwenburgh, C.; Prolla, T. A., Science 2005, 309 (5733), 481; (d) Balaban, R. S.; Nemoto, S.; Finkel, T., Cell 2005, 120 (4), 483. (2) (a) Hoye, A. T.; Davoren, J. E.; Wipf, P.; Fink, M. P.; Kagan, V. E., Acc. Chem. Res. 2008, 41 (1), 87; (b) Murphy, M. P.; Smith, R. A. J., Targeting antioxidants to mitochondria by conjugation to lipophilic cations. In Annual Review of Pharmacology and Toxicology, 2007; Vol. 47, pp 629; (c) Yousif, L. F.; Stewart, K. M.; Kelley, S. O., Chembiochem 2009, 10 (12), 1939. (3) (a) Thomas, D. A.; Stauffer, C.; Zhao, K.; Yang, H.; Sharma, V. K.; Szeto, H. H.; Suthanthiran, M., J. Am. Soc. Nephrol. 2007, 18 (1), 213; (b) Birk, A. V.; Liu, S.; Soong, Y.; Mills, W.; Singh, P.; Warren, J. D.; Seshan, S. V.; Pardee, J. D.; Szeto, H. H., J. Am. Soc. Nephrol. 2013, 24 (8), 1250; (c) Trachootham, D.; Alexandre, J.; Huang, P., Nat. Rev. Drug. Discov. 2009, 8 (7), 579. (4) (a) Yousif, L. F.; Stewart, K. M.; Horton, K. L.; Kelley, S. O., Chembiochem 2009, 10 (12), 2081; (b) Mahon, K. P.; Potocky, T. B.; Blair, D.; Roy, M. D.; Stewart, K. M.; Chiles, T. C.; Kelley, S. O., Chem. & Bio. 2007, 14 (8), 923; (c) Zhao, K. S.; Luo, G. X.; Giannelli, S.; Szeto, H. H., Biochem. Pharmacol. 2005, 70 (12), 1796; (d) Smith, R. A. J.; Porteous, C. M.; Coulter, C. V.; Murphy, M. P., Eur. J. Biochem. 1999, 263 (3), 709; (e) Murphy, M. P.; Smith, R. A., Annu. Rev. Pharmacol. Toxicol. 2007, 47, 629; (f) Murphy, M. P., Trends Biotechnol. 1997, 15 (8), 326; (g) Hurt, E. C.; Muller, U.; Schatz, G., Embo Journal 1985, 4 (13A), 3509; (h) Horton, K. L.; Stewart, K. M.; Fonseca, S. B.; Guo, Q.; Kelley, S. O., Chem. Biol. 2008, 15 (4), 375; (i) Hoye, A. T.; Davoren, J. E.; Wipf, P.; Fink, M. P.; Kagan, V. E., Acc. Chem. Res. 2008, 41 (1), 87. (5) Murphy, M. P., Trends Biotechnol. 1997, 15 (8), 326. (6) He, H.; Wang, H.; Zhou, N.; Yang, D.; Xu, B., Chem. Commun. 2018, 54, 86.
(7) Hopp, T. P.; Prickett, K. S.; Price, V. L.; Libby, R. T.; March, C. J.; Cerretti, D. P.; Urdal, D. L.; Conlon, P. J., Nat. Biotechnol. 1988, 6 (10), 1204. (8) (a) Reches, M.; Gazit, E., Science 2003, 300 (5619), 625; (b) Burattini, S.; Greenland, B. W.; Merino, D. H.; Weng, W.; Seppala, J.; Colquhoun, H. M.; Hayes, W.; Mackay, M. E.; Hamley, I. W.; Rowan, S. J., J. Am. Chem. Soc. 2010, 132 (34), 12051; (c) Zhang, Y.; Kuang, Y.; Gao, Y.; Xu, B., Langmuir 2010, 27 (2), 529. (9) Pavlov, I. P.; Thompson, W. H., The work of the digestive glands. Charles Griffin: 1902. (10) Teale, F.; Dale, R., Biochem. J. 1970, 116 (2), 161. (11) Gao, Y.; Shi, J.; Yuan, D.; Xu, B., Nat. Commun. 2012, 3, 1033. (12) Chan, W. C.; White, P. D., Fmoc solid phase peptide synthesis. Oxford University Press: 2000. (13) Elmore, S., Toxicol. Pathol. 2007, 35 (4), 495. (14) Wikstrom, M. K., Nature 1977, 266 (5599), 271. (15) Goldstein, J. C.; Waterhouse, N. J.; Juin, P.; Evan, G. I.; Green, D. R., Nat. Cell Biol. 2000, 2 (3), 156. (16) Tait, S. W.; Parsons, M. J.; Llambi, F.; Bouchier-Hayes, L.; Connell, S.; Muñoz-Pinedo, C.; Green, D. R., Dev. Cell 2010, 18 (5), 802. (17) Manders, E.; Verbeek, F.; Aten, J., J. Microsc. 1993, 169 (3), 375. (18) Harker, W. G.; Sikic, B. I., Cancer Res. 1985, 45 (9), 4091. (19) Lu, D.; Fütterer, K.; Korolev, S.; Zheng, X.; Tan, K.; Waksman, G.; Sadler, J. E., J. Mol. Biol. 1999, 292 (2), 361. (20) Komiyama, M.; Yoshimoto, K.; Sisido, M.; Ariga, K., Bull. Chem. Soc. Jpn. 2017, 90 (9), 967. (21) Zielonka, J.; Joseph, J.; Sikora, A.; Hardy, M.; Ouari, O.; Vasquez-Vivar, J.; Cheng, G.; Lopez, M.; Kalyanaraman, B., Chem. Rev. 2017, 117 (15), 10043. (22) (a) Yamada, Y.; Akita, H.; Kogure, K.; Kamiya, H.; Harashima, H., Mitochondrion 2007, 7 (1-2), 63; (b) Schatz, G., J. Biol. Chem. 1996, 271 (50), 31763. (23) Green, D. R.; Galluzzi, L.; Kroemer, G., Science 2014, 345 (6203), 1466.
ACS Paragon Plus Environment
Page 4 of 5
Page 5 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of the American Chemical Society
ACS Paragon Plus Environment
5
